Form 4: Iveda Solutions Director's Options Repriced to $0.29

Sentiment:

Statement of Changes in Beneficial Ownership


Iveda Solutions' Director Joseph A. Farnsworth had 100,000 stock options repriced from $0.82 to $0.29 per share by the Board of Directors.

Worse than expectedThe repricing of options from $0.82 to $0.29 per share is generally considered worse for existing shareholders.It effectively lowers the performance hurdle for the director to profit from their options, potentially at the expense of shareholder value if the stock price recovers.This action can dilute the value of existing shares by increasing the likelihood of more options being exercised at a lower price.

Summary

  • Joseph A. Farnsworth, a Director of Iveda Solutions, Inc. (IVDA), had 100,000 stock options repriced.
  • The exercise price for these options was reduced from $0.82 per share to $0.29 per share.
  • The repricing was approved by the Issuer's Board of Directors on February 23, 2026.
  • All other terms of the options, including the exercisable date of December 29, 2025, and expiration date of December 29, 2035, remain unchanged.
  • Following this transaction, Mr. Farnsworth beneficially owns 128,599 derivative securities (options).

Sentiment

Score: 3

Explanation: StockSavvy.ai views this repricing as a negative signal for shareholders, as it suggests past underperformance and potentially dilutes future shareholder value by lowering the bar for executive compensation.

Positives

  • The repricing provides a stronger incentive for Director Joseph A. Farnsworth, as the options are now significantly 'in the money' or closer to being so, potentially aligning his interests with a future stock price recovery.

Negatives

  • Option repricing can be viewed negatively by shareholders as it effectively lowers the performance threshold for the executive to realize value, potentially diluting shareholder value or signaling past underperformance.
  • The repricing may suggest that the company's stock price has fallen significantly below the original strike price, indicating challenges in the company's performance or market perception.

Risks

  • Shareholder dissatisfaction: Option repricing can lead to investor concerns about corporate governance and management's accountability, potentially impacting investor confidence.
  • Perception of misalignment: Repricing options when the stock price has declined can create a perception that management is being rewarded despite poor stock performance, potentially misaligning executive incentives with long-term shareholder value creation.

Future Outlook

No explicit forward-looking statements or guidance are provided in this Form 4 filing beyond the terms of the repriced options.

Management Comments

  • On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged.

Industry Context

StockSavvy.ai notes that option repricing is a common, albeit often controversial, practice in industries where stock prices have experienced significant declines. It is typically employed to re-incentivize management and retain key personnel by making their equity awards more valuable and achievable, especially when original strike prices are far out-of-the-money. However, it can also signal underlying performance issues and raise questions about corporate governance and shareholder alignment.

Comparison to Industry Standards

  • Option repricing is a practice seen across various industries, particularly in technology and growth sectors, when companies face prolonged stock price declines.
  • For example, companies like Zynga (in 2012) and Groupon (in 2013) have undertaken similar repricing initiatives to re-motivate executives after significant drops in their stock values.
  • While common, the specific details, such as the magnitude of the price reduction (from $0.82 to $0.29, a ~64.6% reduction), would need to be compared against peer companies' repricing events to assess if it falls within typical industry ranges for similar circumstances.
  • The decision by Iveda Solutions' Board to reprice options for a director suggests a strategic move to maintain executive incentive, a practice often debated for its impact on shareholder value versus executive retention.

Management Changes

RolePrevious PersonNew PersonEffective DateReason

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PolicyThe Issuer's Board of Directors approved the repricing of 100,000 stock options for Director Joseph A. Farnsworth.02/23/2026This action impacts executive incentive structure and may raise questions about the Board's oversight of executive compensation in relation to shareholder value.

Legal Proceedings

  • No legal proceedings or regulatory matters are mentioned.

Related Party Transactions

  • The repricing of stock options for Joseph A. Farnsworth, a Director of Iveda Solutions, Inc., constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: Potential negative impact due to perceived dilution of value and questions regarding executive compensation alignment with performance.
  • Director (Joseph A. Farnsworth): Positive impact through increased incentive and potential for greater personal financial gain from the options.
  • Employees: No direct impact mentioned, but could influence morale if other employees' options are not similarly adjusted.

Next Steps

  • No specific future actions or milestones are mentioned in this Form 4 filing.

Key Dates

DateDescription
12/29/2025Date options became exercisable and original expiration date of options.
02/23/2026Date the Issuer's Board of Directors approved the option repricing.
02/25/2026Signature date of the reporting person on the Form 4 filing.
12/29/2035Expiration date of the repriced options.

Recommendation

hold

While the option repricing itself is a negative signal for shareholders, a Form 4 filing primarily reports a transaction rather than comprehensive financial results. The repricing suggests potential past underperformance and a move to re-incentivize a director, which could be viewed cautiously. However, without broader financial context or strategic updates, a "hold" recommendation is appropriate, advising investors to monitor future company performance and broader market conditions for Iveda Solutions.

Keywords

Iveda Solutions, IVDA, Form 4, Option Repricing, Executive Compensation, Director Options, Stock Options, Corporate Governance, Joseph A. Farnsworth

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.